NanoVibronix announces 1-for-11 reverse stock split effective March 13, 2025

ENvue Medical, Inc.

Reverse split at 1-for-11 ratio; shares outstanding drop from 8,716,327 to ~792,394.
Effective 4:05 p.m. ET on March 13, 2025; split-adjusted trading starts March 14, 2025 on Nasdaq.
No fractional shares issued; fractional shares rounded up to nearest whole share.
CUSIP changes to 63008J702; trading symbol remains NAOV.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ENvue Medical, Inc.: Filed Certificate of Amendment to effect a 1-for-11 reverse stock split of common stock (effective 2025-03-13).

Change: charter amendment
Effective: 2025-03-13

Exact text from the filing

On March 12, 2025, NanoVibronix, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Amended and Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-11 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (Delaware time) on March 13, 2025 (the “ Reverse Stock Split ”).

View on SEC.gov

89 governance changes filed in the last 30 days. Browse all governance changes →

ENvue Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-010040

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.